TFF3 and prostate carcinoma: Increasing number of studies have shown that CBX1, also known as HP1-β, is overexpressed in different type of tumors, including prostate cancer (PRCA), breast cancer (BRCA), and hepatocellular carcinoma (HCC) [13, 32, 33].